1. Pink Sheet

GSK Seeks To Prevent Pfizer From Selling Its Rival RSV Vaccine In the US

 
• By Brenda Sandburg

Claiming Pfizer’s Abrysvo infringes four of its patents, GSK asks court to permanently enjoin Pfizer from making or selling the vaccine in the US but would exempt the pending maternal indication.

RSV vaccine
GSK claims Pfizer's RSV vaccine infringes its patents • Source: Shutterstock

GlaxoSmithKline Biologicals SA moved to derail Pfizer Inc.’s launch of its respiratory syncytial virus (RSV) vaccine Abrysvo for older people by filing a patent infringement suit and seeking a court order preventing Pfizer from making or selling the vaccine in the US. GSK also seeks damages and/or reasonable royalties.

The complaint, filed on 2 August in the US District Court for the District of Delaware, alleges that Abrysvo...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Pink Sheet

US FDA Could Seek Stronger Warnings On SSRI Antidepressant Risks During Pregnancy

 
• By Sue Sutter

Testimony during a July 21 ‘expert panel’ could help justify stronger warnings across the class about potential adverse effects on mother and baby. Panelists ranged from clinicians who said depression during pregnancy should be treated, to those who said sadness has been “medicalized."

World’s First Hemato-Oncology Microbiota Therapeutic Among Latest New EU Filings

 
• By Neena Brizmohun

The European Medicines Agency has started reviewing for potential EU marketing approval six new products, including MaaT Pharma’s microbiota therapeutic for acute-graft-versus-host disease, and AstraZeneca's camizestrant for locally advanced or metastatic breast cancer.

Sponsors Asked, EMA Delivered: One Handbook To Navigate CTIS

 
• By Vibha Sharma

The European Medicines Agency has revised the sponsor handbook for the Clinical Trials Information System, bringing together guidance that was previously scattered across multiple platforms and documents to help sponsors navigate the trial process more efficiently.